Philips Bridge Prep Kit REF: K12-09098C Sterile EO, Rx ONLY Recall
Philips Bridge Prep Kit REF: K12-09098C Sterile EO, Rx ONLY
FDA recall Class II
Ongoing
FDA lists this Class II recall for Philips Bridge Prep Kit REF: K12-09098C Sterile EO, Rx ONLY. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-2004-2026
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Apr 2, 2026
- FDA report date
- May 6, 2026
- Quantity in commerce
- Not reported
- Distribution
- See key details
- FDA cause
- Nonconforming Material/Component
What is being recalled?
Philips Bridge Prep Kit REF: K12-09098C Sterile EO, Rx ONLY
Affected model & UDI checker
Search the exact identifiers published for Z-2004-2026.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| K12-09098C | Philips Bridge Prep Kit REF: K12-09098C Sterile EO, Rx ONLY | Check source notice | Not specified |
| Not specified | Philips Bridge Prep Kit REF: K12-09098C Sterile EO, Rx ONLY | Check source notice | 00884450024140 |
FDA code information
All Lot Numbers/UDI: 00884450024140
Why was this product recalled?
catheter may experience resistance when being advanced over the guidewire
What actions did Merit Medical Systems, Inc. take?
On April 17, 2026, Merit Medical Issued a Urgent Medical Device Recall notification via: FedEx. Initial notification was issued on April 2, 2026 via E-Mail and FedEx. Merit ask consignees to take the following actions: 1. Ensure that applicable personnel within your organization are made aware of this safety notice. 2. If the product has been further distributed to other facilities, institutions, or manufacturers, please immediately share this safety notice in accordance with your company policies. Please consider communicating the following to your customers: a. For continued safe use of the Philips Bridge" and Philips Bridge" Plus Occlusion Balloons, as outlined in the Prophylactic Directions for Use in the IFU, the following actions should be taken prior to the beginning of any procedure to confirm proper interaction between devices: i. After placement of the guidewire, advance the Balloon over the guidewire. This will confirm that the Balloon can freely be advanced over the entire length of the guidewire without resistance, thereby confirming that the guidewire is compatible with the Balloon. ii. Should resistance be felt during this step, the guidewire should be replaced with an alternate 0.035 stiff/super stiff wire, and Step 1 should be repeated prior to the beginning of the procedure. 3. Please circulate this information to all users of the Philips Bridge", Philips Bridge" Plus, and Bridge" Prep Kit device, or to any organization where the affected product may have been transferred, so that they are aware of the issue. Merit encourages you to instruct your customers to post the safety notice on or near the affected products.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-2004-2026
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 20, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 20, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology